267 related articles for article (PubMed ID: 35185875)
1. HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-19 Severity.
Hovhannisyan A; Madelian V; Avagyan S; Nazaretyan M; Hyussyan A; Sirunyan A; Arakelyan R; Manukyan Z; Yepiskoposyan L; Mayilyan KR; Jordan F
Front Immunol; 2022; 13():769900. PubMed ID: 35185875
[TBL] [Abstract][Full Text] [Related]
2. Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients.
Iturrieta-Zuazo I; Rita CG; García-Soidán A; de Malet Pintos-Fonseca A; Alonso-Alarcón N; Pariente-Rodríguez R; Tejeda-Velarde A; Serrano-Villar S; Castañer-Alabau JL; Nieto-Gañán I
Clin Immunol; 2020 Oct; 219():108572. PubMed ID: 32810602
[TBL] [Abstract][Full Text] [Related]
3. HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure.
Khor SS; Omae Y; Nishida N; Sugiyama M; Kinoshita N; Suzuki T; Suzuki M; Suzuki S; Izumi S; Hojo M; Ohmagari N; Mizokami M; Tokunaga K
Front Immunol; 2021; 12():658570. PubMed ID: 33968060
[TBL] [Abstract][Full Text] [Related]
4. Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience.
Littera R; Campagna M; Deidda S; Angioni G; Cipri S; Melis M; Firinu D; Santus S; Lai A; Porcella R; Lai S; Rassu S; Scioscia R; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Serra M; Ragatzu P; Carta MG; Del Giacco S; Restivo A; Deidda S; Orrù S; Palimodde A; Perra R; Orrù G; Conti M; Balestrieri C; Serra G; Onali S; Marongiu F; Perra A; Chessa L
Front Immunol; 2020; 11():605688. PubMed ID: 33343579
[TBL] [Abstract][Full Text] [Related]
5. Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.
Nguyen A; David JK; Maden SK; Wood MA; Weeder BR; Nellore A; Thompson RF
J Virol; 2020 Jun; 94(13):. PubMed ID: 32303592
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility and Severity of COVID-19 Are Both Associated With Lower Overall Viral-Peptide Binding Repertoire of HLA Class I Molecules, Especially in Younger People.
Basir HRG; Majzoobi MM; Ebrahimi S; Noroozbeygi M; Hashemi SH; Keramat F; Mamani M; Eini P; Alizadeh S; Solgi G; Di D
Front Immunol; 2022; 13():891816. PubMed ID: 35911710
[TBL] [Abstract][Full Text] [Related]
7. Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19.
Shkurnikov M; Nersisyan S; Jankevic T; Galatenko A; Gordeev I; Vechorko V; Tonevitsky A
Front Immunol; 2021; 12():641900. PubMed ID: 33732261
[TBL] [Abstract][Full Text] [Related]
8.
Naidoo L; Arumugam T; Ramsuran V
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674456
[TBL] [Abstract][Full Text] [Related]
9. Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19.
Fischer JC; Schmidt AG; Bölke E; Uhrberg M; Keitel V; Feldt T; Jensen B; Häussinger D; Adams O; Schneider EM; Balz V; Enczmann J; Rox J; Hermsen D; Schulze-Bosse K; Kindgen-Milles D; Knoefel WT; van Griensven M; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Pedoto A; Maas K; Schmidt L; Grebe O; Esposito I; Ehrhardt A; Peiper M; Buhren BA; Calles C; Stöhr A; Lichtenberg A; Freise NF; Lutterbeck M; Rezazadeh A; Budach W; Matuschek C
Eur J Med Res; 2021 Sep; 26(1):107. PubMed ID: 34530915
[TBL] [Abstract][Full Text] [Related]
10. HLA repertoire of 115 UAE nationals infected with SARS-CoV-2.
Alnaqbi H; Tay GK; Jelinek HF; Francis A; Alefishat E; El Haj Chehadeh S; Tahir Saeed A; Hussein M; Laila Salameh ; Mahboub BH; Uddin M; Alkaabi N; Alsafar HS;
Hum Immunol; 2022 Jan; 83(1):1-9. PubMed ID: 34462158
[TBL] [Abstract][Full Text] [Related]
11. Association between the HLA genotype and the severity of COVID-19 infection among South Asians.
Naemi FMA; Al-Adwani S; Al-Khatabi H; Al-Nazawi A
J Med Virol; 2021 Jul; 93(7):4430-4437. PubMed ID: 33830530
[TBL] [Abstract][Full Text] [Related]
12. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
[TBL] [Abstract][Full Text] [Related]
13. MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population.
Ben Shachar S; Barda N; Manor S; Israeli S; Dagan N; Carmi S; Balicer R; Zisser B; Louzoun Y
J Clin Immunol; 2021 Aug; 41(6):1154-1161. PubMed ID: 34050837
[TBL] [Abstract][Full Text] [Related]
14. HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19.
Castro-Santos P; Rojas-Martinez A; Riancho JA; Lapunzina P; Flores C; Carracedo Á; Díaz-Peña R;
HLA; 2023 Dec; 102(6):731-739. PubMed ID: 37528566
[TBL] [Abstract][Full Text] [Related]
15. Ancestral origins are associated with SARS-CoV-2 susceptibility and protection in a Florida patient population.
Shen Y; Khatri B; Rananaware S; Li D; Ostrov DA; Jain PK; Lessard CJ; Nguyen CQ
PLoS One; 2023; 18(1):e0276700. PubMed ID: 36649279
[TBL] [Abstract][Full Text] [Related]
16. HLA Allele Frequencies and Association with Severity of COVID-19 Infection in Northern Italian Patients.
Guerini FR; Bolognesi E; Lax A; Bianchi LNC; Caronni A; Zanzottera M; Agliardi C; Albergoni MP; Banfi PI; Navarro J; Clerici M
Cells; 2022 May; 11(11):. PubMed ID: 35681490
[TBL] [Abstract][Full Text] [Related]
17. Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality.
Sakuraba A; Haider H; Sato T
Viruses; 2020 Nov; 12(11):. PubMed ID: 33233780
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
[TBL] [Abstract][Full Text] [Related]
19. HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease.
Hosseini E; Minagar A; Ghasemzadeh M; Arabkhazaeli A; Ghasemzadeh A
Hum Immunol; 2023 Apr; 84(4):263-271. PubMed ID: 36822912
[TBL] [Abstract][Full Text] [Related]
20. Impact of HLA polymorphisms on the susceptibility to SARS-CoV-2 infection and related mortality in patients with renal replacement therapy.
Akcay OF; Yeter HH; Unsal Y; Yasar E; Gonen S; Derici U
Hum Immunol; 2023 Apr; 84(4):272-277. PubMed ID: 36797091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
